June 30, 2020 : DCMS #508 |
|
Letter from the Editor
 The SGLT-2 inhibitors have made a big change in the way we think about diabetes management, and have emphasized how important a role the kidney plays in glucose management and metabolism. We have gone from a total fear of urinary tract infections to a realization of how these medications help with hypertension and heart failure, and it seems that even though most benefits and side effects are class-wide, there are individual differences that can make picking one entity over the other worthwhile for patients.
To help you select the best SGLT-2 inhibitor for your particular patient, our intern, Maya S. Palmer, Doctor of Pharmacy Candidate, Florida A&M University, has prepared a chart for the purpose.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief |
|
